Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hallal David
Relationship:   Director
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   2,920,473    

Indirect Shares

   17,647,006      
Direct Value   $38,917,709    

Indirect Value

   $33,839,013      
Total Shares   20,567,479      
Total Value   $72,756,722      


Alexion Pharmaceuticals Inc $34,541,045 Scholar Rock Holding Corp $2,763,558 Allovir Inc $1,613,106 Seer, Inc. $0 Alexion Pharmaceuticals Inc $34,541,045 Scholar Rock Holding Corp $2,763,558 Allovir Inc $1,613,106 Seer, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -113.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN CEO, Director 2016-08-08 189,266 2014-12-18 113,122    Premium*  
            Scholar Rock Holding Corp SRRK Director 2019-09-18 290,595 2019-09-18 0    Premium*  
            Allovir Inc ALVR 2024-06-06 2,143,662 2024-06-06 17,533,884    Premium*  
            Seer, Inc. SEER Director 2023-06-14 296,950 0    Premium*  
            Iteos Therapeutics, Inc. ITOS Director 2022-06-09 0 2021-12-20 0    Premium*  
* Premium Members only  

Records found :    128         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALXN Alexion Pharmaceuticals I... SVP. Global Commercial Ops   •       –      –    2012-07-31 4 S $104.99 $71,393 D/D (680) 61,975 0 -
ALXN Alexion Pharmaceuticals I... SVP. Global Commercial Ops   •       –      –    2012-10-24 4 OE $8.16 $85,680 D/D 10,500 72,475 0 -
ALXN Alexion Pharmaceuticals I... SVP. Global Commercial Ops   •       –      –    2012-10-24 4 OE $8.16 $85,680 D/D 10,500 72,475 0 -
ALXN Alexion Pharmaceuticals I... EVP. Global Commercial Ops   •       –      –    2013-01-28 4 S $94.50 $59,724 D/D (632) 71,843 0 -
ALXN Alexion Pharmaceuticals I... EVP. Global Commercial Ops   •       –      –    2013-01-29 4 S $94.32 $48,292 D/D (512) 71,331 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-02-04 4 S $95.68 $200,537 D/D (2,085) 69,246 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-02-06 4 A $0.00 $0 D/D 5,400 74,646 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-06-05 4 OE $8.16 $204,281 D/D 15,008 89,654 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-07-12 4 OE $17.65 $882,500 D/D 50,000 139,654 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-07-12 4 AS $120.00 $6,000,000 D/D (50,000) 89,654 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-07-30 4 S $110.86 $82,702 D/D (746) 88,908 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-08-05 4 S $116.87 $85,315 D/D (730) 88,178 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-10-28 4 AS $122.79 $3,691,504 I/I (30,000) 88,178 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-10-28 4 OE $17.98 $539,400 I/I 30,000 118,178 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-10-28 4 AS $122.79 $2,214,901 D/D (18,000) 88,178 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-10-28 4 OE $17.98 $323,640 D/D 18,000 106,178 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-12-09 4 OE $17.98 $192,476 D/D 10,705 120,383 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-12-09 4 AS $127.63 $1,366,279 D/D (10,705) 109,678 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-12-09 4 OE $17.98 $263,173 I/I 14,637 124,315 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-12-09 4 AS $127.63 $1,868,120 I/I (14,637) 109,678 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-12-18 4 AS $127.61 $1,960,472 I/I (15,363) 109,678 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-12-18 4 A $17.98 $276,227 I/I 15,363 125,041 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-12-18 4 AS $127.53 $930,331 D/D (7,295) 109,678 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2013-12-18 4 OE $17.98 $131,164 D/D 7,295 116,973 0 -
ALXN Alexion Pharmaceuticals I... EVP, Chief Commercial Officer   •       –      –    2014-01-29 4 S $133.37 $97,283 D/D (729) 108,949 0 -
  128  Records found
  1   2   3  4   5   6      
  Page 3 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us